Xellia Enters 4 Year Collaboration to Develop New Antibiotics

News   Feb 27, 2013

 
Xellia Enters 4 Year Collaboration to Develop New Antibiotics
 
 
 

RELATED ARTICLES

Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment

News

Scientists validate a biomarker indicative of patients with Glioblastoma prognosis and likely response to specific therapies.

READ MORE

A New Tactic in the Fight Against Drug-Resistant Infections

News

$1 million research grant could lead to life-saving antibiotics.

READ MORE

APEIRON Strengthens Management Board

News

Industry expert Peter Llewellyn-Davies joins as New Chief Financial Officer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE